175 related articles for article (PubMed ID: 25682988)
1. Systematic Implantation of Pacemaker/ICDs under Active Oral Anticoagulation Irrespective of Patient's Individual Preoperative Thromboembolic Risk.
Cano Ó; Andrés A; Jiménez R; Osca J; Alonso P; Rodríguez Y; Sancho-Tello MJ; Olagüe J; Castro JE; Salvador A; Martínez-Dolz L
Pacing Clin Electrophysiol; 2015 Jun; 38(6):723-30. PubMed ID: 25682988
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a new standardized protocol for the perioperative management of chronically anticoagulated patients receiving implantable cardiac arrhythmia devices.
Cano O; Muñoz B; Tejada D; Osca J; Sancho-Tello MJ; Olagüe J; Castro JE; Salvador A
Heart Rhythm; 2012 Mar; 9(3):361-7. PubMed ID: 22001709
[TBL] [Abstract][Full Text] [Related]
3. Perioperative anticoagulation management in patients on chronic oral anticoagulant therapy undergoing cardiac devices implantation: a meta-analysis.
Du L; Zhang Y; Wang W; Hou Y
Pacing Clin Electrophysiol; 2014 Nov; 37(11):1573-86. PubMed ID: 25234639
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular implantable electronic device implantation with uninterrupted dabigatran: comparison to uninterrupted warfarin.
Jennings JM; Robichaux R; McElderry HT; Plumb VJ; Gunter A; Doppalapudi H; Osorio J; Yamada T; Kay GN
J Cardiovasc Electrophysiol; 2013 Oct; 24(10):1125-9. PubMed ID: 23889767
[TBL] [Abstract][Full Text] [Related]
5. Perioperative bridging of chronic oral anticoagulation in patients undergoing pacemaker implantation--a study in 200 patients.
Hammerstingl C; Omran H
Europace; 2011 Sep; 13(9):1304-10. PubMed ID: 21508005
[TBL] [Abstract][Full Text] [Related]
6. Perioperative management of antithrombotic treatment during implantation or revision of cardiac implantable electronic devices: the European Snapshot Survey on Procedural Routines for Electronic Device Implantation (ESS-PREDI).
Deharo JC; Sciaraffia E; Leclercq C; Amara W; Doering M; Bongiorni MG; Chen J; Dagres N; Estner H; Larsen TB; Johansen JB; Potpara TS; Proclemer A; Pison L; Brunet C; Blomström-Lundqvist C;
Europace; 2016 May; 18(5):778-84. PubMed ID: 27226497
[TBL] [Abstract][Full Text] [Related]
7. [Hemorrhagic risk of different perioperative anticoagulation protocols in patients implanted with a cardiac pacemaker or defibrillator: retrospective analysis in patients implanted in a community hospital].
Amara W; Ben Youssef I; Kamel J; Ghrissi I; Faron M; Khouadja A; Sergent J
Ann Cardiol Angeiol (Paris); 2009 Nov; 58(5):265-71. PubMed ID: 19833318
[TBL] [Abstract][Full Text] [Related]
8. Safety of pacemaker and implantable cardioverter-defibrillator implantation during uninterrupted warfarin treatment--the FinPAC study.
Airaksinen KE; Korkeila P; Lund J; Ylitalo A; Karjalainen P; Virtanen V; Raatikainen P; Koivisto UM; Koistinen J
Int J Cardiol; 2013 Oct; 168(4):3679-82. PubMed ID: 23849104
[TBL] [Abstract][Full Text] [Related]
9. Predictors of pocket hematoma in patients on antithrombotic therapy undergoing cardiac rhythm device implantation: insights from the FinPAC trial.
Nammas W; Raatikainen MJ; Korkeila P; Lund J; Ylitalo A; Karjalainen P; Virtanen V; Koivisto UM; Utriainen S; Vasankari T; Koistinen J; Airaksinen KE
Ann Med; 2014 May; 46(3):177-81. PubMed ID: 24785546
[TBL] [Abstract][Full Text] [Related]
10. Implantation of cardiac rhythm devices without interruption of oral anticoagulation compared with perioperative bridging with low-molecular weight heparin.
Tischenko A; Gula LJ; Yee R; Klein GJ; Skanes AC; Krahn AD
Am Heart J; 2009 Aug; 158(2):252-6. PubMed ID: 19619702
[TBL] [Abstract][Full Text] [Related]
11. Pocket hematoma after pacemaker or implantable cardioverter defibrillator surgery: influence of patient morbidity, operation strategy, and perioperative antiplatelet/anticoagulation therapy.
Wiegand UK; LeJeune D; Boguschewski F; Bonnemeier H; Eberhardt F; Schunkert H; Bode F
Chest; 2004 Oct; 126(4):1177-86. PubMed ID: 15486380
[TBL] [Abstract][Full Text] [Related]
12. The relationship between warfarin, aspirin, and clopidogrel continuation in the peri-procedural period and the incidence of hematoma formation after device implantation.
Thal S; Moukabary T; Boyella R; Shanmugasundaram M; Pierce MK; Thai H; Goldman S
Pacing Clin Electrophysiol; 2010 Apr; 33(4):385-8. PubMed ID: 20059711
[TBL] [Abstract][Full Text] [Related]
13. Strategy of continued vs interrupted novel oral anticoagulant at time of device surgery in patients with moderate to high risk of arterial thromboembolic events: The BRUISE CONTROL-2 trial.
Essebag V; Healey JS; Ayala-Paredes F; Kalfon E; Coutu B; Nery P; Verma A; Sapp J; Philippon F; Sandhu RK; Coyle D; Eikelboom J; Wells G; Birnie DH
Am Heart J; 2016 Mar; 173():102-7. PubMed ID: 26920602
[TBL] [Abstract][Full Text] [Related]
14. Risk of hematoma complications after device implant in the clopidogrel era.
Kutinsky IB; Jarandilla R; Jewett M; Haines DE
Circ Arrhythm Electrophysiol; 2010 Aug; 3(4):312-8. PubMed ID: 20558847
[TBL] [Abstract][Full Text] [Related]
15. Continuing warfarin therapy is superior to interrupting warfarin with or without bridging anticoagulation therapy in patients undergoing pacemaker and defibrillator implantation.
Ahmed I; Gertner E; Nelson WB; House CM; Dahiya R; Anderson CP; Benditt DG; Zhu DW
Heart Rhythm; 2010 Jun; 7(6):745-9. PubMed ID: 20176137
[TBL] [Abstract][Full Text] [Related]
16. Treatment with novel oral anticoagulants in a real-world cohort of patients undergoing cardiac rhythm device implantations.
Kosiuk J; Koutalas E; Doering M; Sommer P; Rolf S; Breithardt OA; Nedios S; Dinov B; Hindricks G; Richter S; Bollmann A
Europace; 2014 Jul; 16(7):1028-32. PubMed ID: 24489073
[TBL] [Abstract][Full Text] [Related]
17. Oral anticoagulation continuation compared with heparin bridging therapy among high risk patients undergoing implantation of cardiac rhythm devices: a meta-analysis.
Feng L; Li Y; Li J; Yu B
Thromb Haemost; 2012 Dec; 108(6):1124-31. PubMed ID: 23051884
[TBL] [Abstract][Full Text] [Related]
18. Implanting cardiac rhythm devices during uninterrupted warfarin therapy: a prospective, single center experience.
Crosato M; Calzolari V; Franceschini Grisolia E; Daniotti A; Baldessin F; Mantovan R; Olivari Z
J Cardiovasc Med (Hagerstown); 2015 Jul; 16(7):503-6. PubMed ID: 25022924
[TBL] [Abstract][Full Text] [Related]
19. Perioperative anticoagulation in patients having implantation of a cardiac pacemaker or defibrillator: a systematic review and practical management guide.
Jamula E; Douketis JD; Schulman S
J Thromb Haemost; 2008 Oct; 6(10):1615-21. PubMed ID: 18638011
[TBL] [Abstract][Full Text] [Related]
20. Cardiac resynchronization therapy device implantation in patients with therapeutic international normalized ratios.
Ghanbari H; Feldman D; Schmidt M; Ottino J; Machado C; Akoum N; Wall TS; Daccarett M
Pacing Clin Electrophysiol; 2010 Apr; 33(4):400-6. PubMed ID: 20180915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
